OBJECTIVES: There are limited data on aortic root replacement (ARR) in patients with previous cardiac surgery. We analysed short-term and long-term results for patients with ARR after previous cardiac surgery.
INTRODUCTION
The surgical treatment of aortic root aneurysms with a mechanical composite graft was first described by Bentall and de Bono [1] . Since then, further improvements have been made. Today, root replacement (RR) with different prostheses [1] [2] [3] [4] or by valve-sparing techniques [5, 6] are part of the surgical armamentarium, at least in reference centres. RR has been shown to be safe in elective and firsttime operations [7] [8] [9] [10] . It is more challenging in reoperative scenarios, and there are limited data on aortic RR (ARR) in patients with previous cardiac surgery. Even though low operative mortality of less than 5% has been reported [11] , others have described an even higher hospital mortality especially in emergency scenarios [12] . Importantly, long-term survival has also been limited [13] [14] [15] . There is only limited information regarding predictors for early mortality and late mortality. Such information would be important for better decision-making for or against RR after previous cardiac surgery.
The aim of the present study was to analyse the short-term and long-term outcomes of reoperative ARR after previous ARR or previous aortic valve surgery with special focus on predictors of early and long-term survival.
PATIENTS AND METHODS Patients
From October 1995 to April 2015, 1677 patients underwent RR in our institution. Of these, 130 patients who underwent reoperative ARR were selected for further analysis. The investigative study was approved by the regional ethics committee for the analysis and publication of patient data in anonymized fashion. All patients gave their consent.
The primary indications for reoperation were active endocarditis in 65 patients (50%), aneurysmatic root dilatation in another 37 (28.5%) and valve failure in 27 (20.8%). All procedures were performed using standard techniques [1] [2] [3] [4] [5] [6] .
In 50 individuals, RR was performed after previous ARR (Group I). Eighty patients underwent ARR after isolated aortic valve replacement or repair (Group II). In Group I, previous RR had mainly been performed using a mechanical composite (n = 27, 54%), stentless biologic prostheses (n = 11, 22%) or valve-sparing RR (n = 7, 14%; Table 1 ). The number of previous operations ranged from 1-4, and 14 individuals (28%) had undergone more than 1 RR formerly. In Group II, mechanical (n = 45, 56.2%) or biologic (n = 23, 28.8%) valve replacement had been performed previously, and 12 (15%) patients had undergone valve repair (Table 1) . In this group, the number of previous operations ranged from 1 to 3, and 22 patients (27.5%) had undergone more than 1 previous operation.
Patient age was significantly higher in patients receiving stentless biologic ARR (67 ± 11 years) compared to those with mechanical composite (50 ± 4 years; P < 0.001). The lowest age was observed in patients undergoing either the Ross procedure (31 ± 15 years) or valve-sparing ARR (36 ± 7 years).
Operative techniques
The chest was reopened via a median sternotomy, and extracorporeal circulation was established by aortic and right atrial cannulation. In 4 instances, it was initiated prior to sternotomy using femoral cannulation. In the presence of acute aortic dissection, the right axillary artery was used for arterial inflow and the right femoral vein for drainage. If extensive aortic aneurysm required additional replacement of the aortic arch, circulatory arrest under deep hypothermia (nasopharyngeal temperature 18-21 C) was used. After careful dissection of adhesions, the aorta was transected above the commissures, and antegrade cardioplegia was given directly into the coronary ostia. Subsequently, the ostia were excised. After previous valve-preserving surgery, the native aortic valve was carefully inspected. In the absence of cusp retraction or perforations requiring extensive cusp replacement, valve-preserving RR by either root remodelling (n = 7, 5.4%) or valve reimplantation (n = 1, 0.8%) was performed. If valve preservation was not feasible, valve replacement was performed. If valve reimplantation had been performed previously, the implanted Dacron graft was removed completely followed by root remodelling [16] . After aortic valve replacement, the implanted prosthesis was removed completely.
After RR, the coronary arteries were anastomosed directly to the graft. Insufficient mobilization required extension of the left coronary artery with a 6-mm polytetrafluoroethylene (PTFE) prosthesis in 2 patients.
Cardiac comorbidities requiring additional surgery were present in 23 individuals (17.7%, Table 1 ). 
Follow-up
All patients were followed up clinically and echocardiographically. Aortic valve function was analysed according to current echocardiographic recommendations [17] . One patient was lost to follow-up, and follow-up was complete in 98.7% of patients (range 0-19 years). Primary end points were the occurrence of death and the need for reoperation. Valve-related complications (secondary end points) were defined as occurrence of endocarditis, stroke or bleeding.
Statistical analyses
Statistical analysis was performed using the SAS 9.1 software (SAS institute, Inc., Cary, NC, USA) and R version 3.2.4 (cmprsk package). All categorical variables are described as absolute and relative frequencies, and comparison between groups was done using the v 2 or Fisher's exact test. Continuous variables are shown as mean ± standard deviation, and group comparison was assessed using the 2-sample t-test or Mann-Whitney U-test. Binary logistic regression was performed to identify risk factors of early mortality, and Cox proportional hazard regression modelling was used to identify predictors of survival-and valve-related complications. Multivariable regression models were computed using stepwise regression. The Kaplan-Meier curves were constructed using PRISM (GraphPad Software, Inc., La Jolla, CA, USA), and group comparisons were made using the log-rank test. Significance level was set at P-value <0.05.
RESULTS

Perioperative mortality and morbidity
Hospital mortality was 10% (13 patients); it was 8% in Group I (4/ 50 patients) and 11.3% (9/80 patients) in Group II (P = 0.34). It was 12.3% (8/65) in patients operated for acute endocarditis compared to 7.7% (5/65) in patients without endocarditis (P = 0.56). The causes of death were septic multiorgan failure in 9 patients and low cardiac output in 4. Fifteen patients (11.5%) required early re-exploration for haemorrhage. Age, the need for concomitant cardiac surgery, concomitant coronary artery bypass graft (CABG) and re-exploration for haemorrhage were identified as risk factors for early mortality (Table 2) .
Survival
An additional 39 (30%) patients died during follow-up. Survival at 10 and 15 years was 59.4% (SE 5.3%) and 40.6% (SE 6.3%; Fig. 1 ). It was 71.5% (SE 8.4%) and 62.5% (SE 11.1%) in Group I and 56.2% (SE 6.2%) and 35.4% (SE 7.0%) in Group II (P = 0.14; Fig. 2 ). Patients who were operated for active endocarditis showed a significantly worse survival at 10 and 15 years [34.5% (SE 8.1%) and 23.7% (SE 8.5%) vs 81.8% (SE 5.4%) and 56.4% (SE 8.5%), P < 0.001; Fig. 3 ]. Significantly inferior survival was also observed for patients requiring concomitant surgery for cardiac comorbidities (i.e. mitral/tricuspid valve repair/replacement or CABG; Fig. 4) . It was 31.6% (SE 11.5%) and 10.5% (SE 9.8%) at 10 and 15 years compared to 66% (SE 5.7%) and 48.7% (SE 6.7%) for patients without concomitant surgery, respectively (P = 0.003; Fig. 4) . It was 44.5% (SE 7.0%) at 10 years and 26.8% (SE 7.2%) at 15 years compared to 77.5% (SE 7.2%) and 59.5% (SE 9.6%) in younger individuals (P < 0.001). The presence of coronary artery disease had a similar effect in univariable analysis [10-and 15-year survival: 47.4% (SE 10.9%) and 24.4% (SE 11.2%) vs 62.7% (SE 6.0%) and 45.9% (SE 7.1%), P = 0.021].
Further analyses were made excluding patients operated for active endocarditis. In the remaining 65 patients (50%), a similarly worse survival was observed for patients with concomitant surgery compared to patients operated by RR only [60% (SE 14.5%) and 20% (SE 18.2%) vs 85.3% (SE 5.8%) and 64.4% (SE 8.6%) at 10 Patients after stentless biologic replacement showed the worst 10-and 15-year survival [38.3% (SE 6.9%) and 26.7% (SE 6.9%)] followed by those after mechanical composite replacement [84.9% (SE 6.6%) and 56.2% (SE 11.7%); Fig. 5 ]. The best 10-year survival was observed after either the Ross procedure (85.7%, SE 13.2%) or valve-sparing ARR (100%; P < 0.001; Fig. 5 ).
Multivariable analyses were computed for survival with the following confounders: age, gender, active endocarditis, coronary artery disease, additional cardiac surgery, Group I/II and stentless versus composite RR. Because of the relatively small number of patients after the Ross procedure and valve-sparing RR, those 2 groups were not included for multivariable analysis. Backward Cox regression model identified age, active endocarditis and concomitant surgery for cardiac comorbidities as risk factors for death (Table 3) .
Freedom from reoperation
During follow-up, 3 patients in Group I required reoperation on aortic valve or root for either recurrent endocarditis (n = 2) or degeneration of the pulmonary autograft (n = 1). In Group II, 1 patient was reoperated for recurrent endocarditis. Freedom from reoperation at 5, 10 and 15 years was 97.6% (SE 2.4%), 91.5% (SE 6.3%) and 80% (SE 12.0%) in Group I and 96.8% (SE 3.2%) at 5, 10 and 15 years in Group II (P = 0.036).
Valve-related long-term morbidity
In Group I, 1 patient experienced an anticoagulation-related bleeding complication. There was 1 stroke, and 2 patients developed recurrent endocarditis requiring reoperation. Another patient in Group II exhibited a bleeding complication. Two patients developed recurrent endocarditis and died. There was no postoperative stroke in this group. Freedom from valve-related morbidity after 10 and 15 years was 82.2% (SE 9.4%) vs 95.3% (SE 3.3%) and 71.9% (SE 12.7%) vs 91.1% (SE 5.1%), respectively (P = 0.061).
DISCUSSION
Since its first description by Bentall and De Bono [1] , RR in different forms [1] [2] [3] [4] [5] [6] has become an accepted treatment for different pathological entities, such as root aneurysm, dissection or endocarditic destruction with extensive perivalvular abscess formation. RR has also become a standard procedure for aortic valve disease if treated with a pulmonary autograft [3] . In experienced hands, RR is performed with low morbidity and mortality [7] [8] [9] [10] . Nevertheless, RR still carries a somewhat higher risk than isolated aortic valve replacement, possibly related to the potential complexity of coronary artery reimplantation [15] . In comparison, RR as a reoperative procedure is more complex and challenging. This is in most instances related to the mobilization of the coronary arteries in the presence of scarring and altered anatomy through the initial procedure and the additional pathology that has to be treated. The incidence of operative haemorrhage is higher, and coronary bypass or interposition grafts are not infrequently used. Accordingly, morbidity and mortality of reoperative RR has been higher than that of a primary procedure in many hands, in particular when performed after previous RR [12] [13] [14] [15] .
In the past years, several series with low operative mortality rates have been published for reoperative RR [11, 13, 14] . On the other hand, a more recent series [18] presented a more sobering view despite coming from a centre with relevant experience in RR. Also, in our current analysis, hospital mortality was 10% and thus not negligible. These differences raise the question whether the results of surgery are mainly determined by surgical technique and experience or whether preoperative factors determine the results. Technical challenges mainly deal with restoration of coronary anatomy, which is more difficult in the presence of scarring and/or dislocation. For this reason, a relevant proportion of the procedures in other series have included coronary bypass or interposition grafts [13 (5%), 14 (22.6%) and 18 (14.2%)]. In our series, direct implantation of the ostia was almost always possible, and in fact, an interposition graft was used in only 2 instances. Interestingly, there was no difference in mortality between RR as reoperation and repeat RR in our study.
A possible aspect explaining the differences between the series is related to differences in patient cohorts. We had included a high proportion of patient with active infective endocarditis and extensive perivalvular abscess formation (50%). These were almost exclusively treated on an urgent or emergency basis. In comparison, in other series, the presence of active endocarditis varied between 18% and 37% [13, 14, 18] .
The most surprising findings were the long-term results, especially in patients treated for endocarditis. Their prognosis was dismal with a 10-year survival of only 34.5%. Patients treated for aneurysmal disease or stable valve disease, on the other hand, had a 10-year survival of 81.8%. The reason for this observation is not clear. Death due to recurrence of endocarditis would be expected in the first 2-3 years, but the attrition also continued at a later phase. One might assume that non-cardiac long-term consequences of endocarditis could have a negative impact in the long term or that unidentified risk factors that contributed to the disease also had a negative chronic impact. On the other hand, this observation confirms the poor long-term prognosis of aortic valve endocarditis described by others [19] . It may raise the question whether current concepts of treating active endocarditis are sufficient to cure the disease [20] . On the other hand, if the results cannot be improved by different medical approach, a more liberal use of biologic prostheses appears justified as most patients will not live to experience their degeneration.
The fact that short-term mortality and long-term mortality were higher in elderly patients is not surprising as surgical procedures in the elderly are known to carry a higher risk. Interestingly, concomitant surgery for either mitral or tricuspid valve and the presence of coronary artery disease were identified as risk factors for death as well.
The presence of coronary artery disease correlated with inferior long-term survival in univariable analysis. This finding is not surprising when considering the dismal long-term prognosis of coronary artery disease and may explain differences between the different series [11] [12] [13] [14] [15] .
It is unclear why concomitant surgical treatment on the mitral valve increases the risk of death. In the most recent series by Esaki et al. [18] , concomitant surgery in this instance was also related to inferior survival. In our analysis, this observation could be confirmed both in univariable analysis and multivariable analysis. Even though extracorporeal circulation and myocardial ischaemia were significantly longer in those patients and surgical trauma is mildly increased, this is an unlikely explanation. The fact that functional and not structural mitral valve disease was present in the majority of those patients might indicate a higher left ventricular degree of dysfunction. Thus, one could argue that a higher degree of left-ventricular failure was present in these patients, leading to a dismal long-term survival.
In comparison, patients after stentless biologic ARR showed the worst survival followed by those after mechanical composite replacement. The best survival was observed in patients after either the Ross procedure or root remodelling. This observation might be influenced by the fact that patient age was higher in those with biologic ARR compared to all other groups. Interestingly, a subanalysis for patients beyond the age of 50 years showed a statistically inferior survival after biologic ARR compared to patients after mechanical composite again. Another shortcoming of this analysis is the small number of patients who have undergone a Ross procedure or valve sparing ARR what makes statistical analysis questionable. Considering these facts, a definite conclusion regarding the different operative procedures is difficult. Nevertheless, we can demonstrate a good survival in younger patients after a Ross or a valve-sparing procedure in our experience so far. Patient age might have influenced the outcome in the 2 major groups, but we are uncertain if this is the only explanation for the impressive attrition after biologic ARR.
The fact that ARR after isolated valve surgery has led to better freedom from reoperation and lower valve-related morbidity might reflect a superior prognosis due to less comorbidity. On the other hand, one must consider the small number of events in both groups. Thus, these observations should not be overstated despite the fact that statistical analysis brought up significant differences.
Limitations
This is a retrospective study and has the limitations inherent to this kind of analysis. We have observed different variations in patient characteristics and number, which likely influenced the prognosis. Accordingly, several subanalyses were performed to prevent a certain bias as best as possible. Despite the fact that some statistics must be interpreted with caution, the key findings of this study reflect our clinical observations.
CONCLUSION
The current findings once again highlight the complexity of reoperative ARR. Short-term mortality and morbidity were reasonable, especially when considering the number of patients undergoing surgery in emergency or increased risk scenarios. The rate of reoperation was low, as was the incidence of valve-related morbidities.
The fact that long-term survival was reduced in patients with cardiac comorbidities reflects an inferior prognosis with more complex disease. The treatment of active endocarditis especially in reoperative cardiac surgery remains challenging. Because of the dismal survival associated with it, even after an uneventful short-term period and mid-term period, one should reconsider the adequacy of the current principles of treatment.
